| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 73.5019 | 70 |
| GSM780708 | Untreated after 4 days (C2_1) | 61.4678 | 65 |
| GSM780709 | Untreated after 4 days (C3_1) | 65.0458 | 67 |
| GSM780719 | Untreated after 4 days (C1_2) | 64.0546 | 67 |
| GSM780720 | Untreated after 4 days (C2_2) | 69.3371 | 69 |
| GSM780721 | Untreated after 4 days (C3_2) | 63.2808 | 66 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 76.7029 | 71 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 65.5694 | 67 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 58.9141 | 64 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 53.0905 | 56 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.0743 | 49 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 56.4768 | 61 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 65.6163 | 67 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 64.3828 | 67 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 55.9081 | 61 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 59.2609 | 64 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 62.0779 | 66 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 60.2478 | 65 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.2284 | 23 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 62.3505 | 66 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 64.2264 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 55.555 | 60 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 66.2835 | 68 |